News Companies Counsel

StockRadar

© 2026 StockRadar. AI-scored stock news, in real time.

Product

News Companies AI Counsel

Legal

Privacy policy Terms and conditions

NVS · Novartis AG | StockRadar

NVS

Novartis AG

·225.465B·Unverified

+84 stories · 30d

Stories (30d): 4
Tracks news: No
Lower alert: —
Higher alert: —
Updated: Sep 28, 2026

Twitter

Recent stories

+8
Novartis invests heavily in Chinese biotech RNA drugs.
1 source·02/10, 16:06·yahoo.com
+8
Novartis signs lucrative RNA therapy deal with Abogen.
1 source·02/10, 10:33·finviz.com
+8
Novartis shows strong momentum and growth potential.
source

All recent news (20)

+8
Novartis wagers almost $8B on a Chinese biotechs RNA drugs
finviz·yahoo.com·02/10, 15:06
+8
Novartis is licensing an mRNA autoimmune therapy from China's Abogen for up to $7.8 billion
finviz·qz.com·02/10, 14:06
+8
Novartis licenses Abogen mRNA autoimmune drug in $7.8B deal
finviz·yahoo.com·02/10, 13:41

1

·09/06, 15:32

-2

Bristol Myers partners with BioNTech for oncology drug.

1 source·03/06, 17:21·finviz.com

0

Article focuses on Novartis AG's stock performance.

1 source·27/05, 14:16·yahoo.com

+7

Novartis AG poised for sustained future growth.

1 source·27/05, 13:57·finviz.com

+8

Novartis starts tender offer to acquire Regulus Therapeutics.

1 source·27/05, 12:09·yahoo.com

0

Gilead reports positive data on breast cancer drug.

1 source·26/05, 14:33·finviz.com

0

Regeneron shows promising results; no impact on Novartis.

1 source·23/05, 21:20·finviz.com

-5

Novartis faces lawsuit over asthma drug and autism claims.

1 source·21/05, 20:02·yahoo.com

+8

Novartis Signs RNA Therapy Licensing Deal With China's Abogen Worth Up to $7.8 Billion

finviz·finviz.com·02/10, 10:25

+8

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term

·yahoo.com·09/06, 14:32

-2

Bristol Myers Collaborates With BNTX for Oncology Candidate

·finviz.com·03/06, 17:21

0

What Makes Novartis AG (NVS) a Differentiated Business?

·yahoo.com·27/05, 13:56

+7

What Makes Novartis AG (NVS) a Differentiated Business?

·finviz.com·27/05, 13:57

+8

Novartis announces commencement of tender offer to acquire Regulus Therapeutics

·yahoo.com·27/05, 12:09

0

GILD Announces Positive Data on Trodelvy in First-Line Breast Cancer

·finviz.com·26/05, 14:33

0

Regeneron Initial Data on Multiple Myeloma Drug Encouraging

·finviz.com·23/05, 21:20

-5

Market Chatter: Court Denies Novartis' Motion to Dismiss Lawsuit Alleging Asthma Drug Caused Autism

·yahoo.com·21/05, 19:34

+8

Are You Looking for a High-Growth Dividend Stock?

·yahoo.com·21/05, 16:01

+7

Are You Looking for a High-Growth Dividend Stock?

·finviz.com·21/05, 16:49

0

Companies Are Planning to Build Factories In America. Are Trump's Tariffs Working?

·investopedia.com·20/05, 10:09

+4

Incyte Gets FDA Approval for Zynyz in New Cancer Indication

·finviz.com·16/05, 16:05

+8

·x.com·15/05, 13:50

+7

Novartis (NVS) Upgraded to Buy: What Does It Mean for the Stock?

·yahoo.com·15/05, 16:29

+6

Novartis (NVS) Upgraded to Buy: What Does It Mean for the Stock?

·finviz.com·15/05, 17:16

+8

New Novartis data at ASCO and EHA showcase momentum of pioneering portfolio with promising pipeline

·yahoo.com·15/05, 13:00